Optimized workplace risk mitigation measures for SARS-CoV-2 in 2022.

Pettit, Rowland; Peng, Bo; Yu, Patrick; Matos, Peter G; Greninger, Alexander L; McCashin, Julie; Amos, Christopher Ian

Pettit, Rowland; Peng, Bo; Yu, Patrick; Matos, Peter G; Greninger, Alexander L; McCashin, Julie; Amos, Christopher Ian.

Afiliação

Pettit R; Institute for Clinical and Translational Research, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.
Peng B; Institute for Clinical and Translational Research, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.
Yu P; Corporate Medical Advisors, Houston, TX, USA.
Matos PG; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.
Greninger AL; Corporate Medical Advisors, Houston, TX, USA.
McCashin J; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.
Amos CI; International S.O.S., Houston, TX, USA.

Sci Rep ; 13(1): 2779, 2023 02 16.

Article em En | MEDLINE | ID: mdl-36797293

Assuntos

COVID-19; SARS-CoV-2; Humanos; Teste para COVID-19; COVID-19/epidemiologia; COVID-19/prevenção & controle; Local de Trabalho

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google